Accounts Receivable, after Allowance for Credit Loss, Current in USD of Caris Life Sciences, Inc. from Q4 2024 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
Caris Life Sciences, Inc. quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and change rate from Q4 2024 to Q3 2025.
  • Caris Life Sciences, Inc. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 30 Sep 2025 was $26,697,000.
Source SEC data
View on sec.gov
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)

Caris Life Sciences, Inc. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $26,697,000 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $50,889,000 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q4 2024 $88,244,000 31 Dec 2024 10-Q 05 Nov 2025 2025 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.